Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study

被引：0
|
作者：
Pozzilli, C. [1 ]
Phillips, J. T. [2 ]
Fox, R. J. [3 ]
Selmaj, K. [4 ]
Zhang, R. [5 ]
Novas, M. [5 ]
Sweetser, M. T. [5 ]
Gold, R. [6 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Med Univ Lodz, Lodz, Poland
[5] Biogen Idec Inc, Cambridge, MA USA
[6] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P066
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [31] Rate of Brain Volume Loss with Long-Term Delayed-Release Dimethyl Fumarate Treatment in Patients with Relapsing-Remitting Multiple Sclerosis: 6-Year Results from ENDORSE
    Kappos, Ludwig
    Yousry, Tarek
    Fox, Robert
    Gold, Ralf
    Arnold, Douglas
    Potts, James
    Marantz, Jing
    NEUROLOGY, 2016, 86
  • [32] Longer-Term Follow-Up of the Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: Integrated Analysis of DEFINE, CONFIRM and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert
    Zhang, Annie
    Taylor, Catherine
    Marantz, Jing
    NEUROLOGY, 2016, 86
  • [33] Long-term safety and tolerability of oral BG-12 (dimethyl fumarate) in relapsing-remitting multiple sclerosis: interim results from ENDORSE
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Raghupathi, K.
    O'Gorman, J.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 517 - 518
  • [34] Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years' Follow-up of DEFINE, CONFIRM, and ENDORSE (vol 13, pg 1, 2020)
    Gold, R.
    Arnold, D. L.
    Bar-Or, A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [35] Real-world Efficacy of Delayed-Release Dimethyl Fumarate in Early Multiple Sclerosis: Interim Results from ESTEEM
    Giles, Kathryn
    Balashov, Konstantin
    Jones, Cynthia C.
    Macdonell, Richard
    Miller, Catherine
    Windsheimer, Joerg
    Wu, Fan
    Everage, Nicholas J.
    NEUROLOGY, 2019, 92 (15)
  • [36] Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM
    Giles, K.
    Balashov, K.
    Jones, C. C.
    Macdonell, R.
    Miller, C.
    Windsheimer, J.
    Wu, F.
    Everage, N. J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 289 - 290
  • [37] Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Meltzer, Leslie
    Kurukulasuriya, Nuwan C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 57 - 66
  • [38] Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Fox, Robert J.
    Kappos, Ludwig
    Mokliatchouk, Oksana
    Jiang, Xiaotong
    Lyons, Jennifer
    Kapadia, Shivani
    Miller, Catherine
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (05) : 801 - 816
  • [39] Radiological findings suggest long-term treatment with delayed-release dimethyl fumarate is associated with tissue and axonal preservation
    Arnold, D. L.
    Kappos, L.
    Gold, R.
    Chen, C.
    Yang, L.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 288 - 289
  • [40] Long-Term Safety and Effectiveness of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice, an updated analysis of the ESTEEM Study
    Pandey, Krupa
    Giles, Kathryn
    Balashov, Konstantin
    Macdonell, Richard
    Windsheimer, Jorg
    Martinez, Mikel
    Bozin, Ivan
    Jiang, Xiaotong
    Lyons, Jennifer
    Mokliatchouk, Oksana
    Okai, Annette
    NEUROLOGY, 2023, 100 (17)
12345